911825-75-7

Upstream product

• 20781-20-8 2,4-Dimethoxybenzylamine 
• 16013-85-7 2,6-dicholoro-3-nitropyridine 
• 1026789-59-2 (R)-tert-butyl 2,4-dimethoxybenzyl-(5-nitro-6-(1-(pyridin-3-yl)ethylamino)pyridin-2-yl)carbamate 
• 911825-74-6 (R)-N₆-(2,4-dimethoxybenzyl)-3-nitro-N₂-(1-(pyridin-3-yl)ethyl)pyridine-2,6-diamine 
• 1083301-53-4 C₁₂H₁₁ClN₄O₂ 
• 40154-75-4 (R)-1-(pyridin-3-yl)ethan-1-amine 
• 1026789-60-5 (R)-tert-butyl 2,4-dimethoxybenzyl-(5-amino-6-(1-(pyridin-3-yl)ethylamino)pyridin-2-yl)carbamate 
• 530-62-1 1,1'-carbonyldiimidazole 

Downstream Products

• 1026789-62-7 (R)-tert-butyl 5-(2-amino-5-cyanophenylamino)-2-oxo-3-(1-(pyridin-3-yl)ethyl)-2,3-dihydroimidazo[4,5-b]pyridine-1-carboxylate 
• 911825-77-9 (R)-tert-butyl 5-(5-cyano-2-nitrophenylamino)-2-oxo-3-(1-(pyridin-3-yl)ethyl)-2,3-dihydroimidazo[4,5-b]pyridine-1-carboxylate 

Relevant academic research and scientific papers

7-Substituted Purine Derivatives for Immunosuppression

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:

7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula (III).

PURINE AND IMIDAZOPYRIDINE DERIVATIVES FOR IMMUNOSUPPRESSION

The present invention provides novel purine and imidazopyridine derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formulas ( I ) and ( II ).